Montag & Associates’s Embecta EMBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-296
Closed -$3.93K – 988
2024
Q1
$3.93K Hold
296
– – ﹤0.01% 832
2023
Q4
$5.6K Hold
296
– – ﹤0.01% 818
2023
Q3
$4.46K Hold
296
– – ﹤0.01% 812
2023
Q2
$6.39K Hold
296
– – ﹤0.01% 805
2023
Q1
$8.32K Sell
296
-591
-67% -$16.8K ﹤0.01% 763
2022
Q4
$22.6K Sell
887
-139
-14% -$4.25K ﹤0.01% 651
2022
Q3
$30K Sell
1,026
-530
-34% -$15.7K ﹤0.01% 614
2022
Q2
$39K Buy
+1,556
New +$44.8K ﹤0.01% 563

Other funds holding EMBC

Montag & Associates's EMBC Position: Q2 2024 in Review

Montag & Associates sold out of Embecta (EMBC) in Q2 2024, closing a stake of 296 shares — an estimated $3.93K sold.

Montag & Associates first reported a position in EMBC in Q2 2022 and held it in 8 quarters. The position peaked at $39K in Q2 2022. 362 funds tracked by Wall St. Rank hold EMBC as of Q2 2024.

  • Montag & Associates reported no remaining Embecta position as of Q2 2024 after selling out during the quarter.
  • Montag & Associates sold 296 Embecta shares in Q2 2024, an estimated $3.93K.
  • Montag & Associates first reported a position in Embecta in Q2 2022 and held it in 8 quarters.
  • Montag & Associates's Embecta position peaked at $39K in Q2 2022.
  • 362 funds tracked by Wall St. Rank held Embecta as of Q2 2024.

Based on Montag & Associates's 13F filing for Q2 2024, filed 31 Jul 2024.